3-(4'-chlorophenyl)-4-hydroxy-5-<(tert-butylamino)methyl>acetanilide | 79287-26-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-(4'-chlorophenyl)-4-hydroxy-5-<(tert-butylamino)methyl>acetanilide
• 英文别名: N-[3-[(tert-butylamino)methyl]-5-(4-chlorophenyl)-4-hydroxyphenyl]acetamide
• CAS: 79287-26-6
• 化学式: C₁₉H₂₃ClN₂O₂
• 分子量: 346.857
• InChiKey: BOWYHIOPVAMYPS-UHFFFAOYSA-N

物化性质

• 沸点：
  514.4±50.0 °C(Predicted)
• 密度：
  1.198±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  24
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.32
• 拓扑面积：
  61.4
• 氢给体数：
  3
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  3-(4'-chlorophenyl)-4-hydroxy-5-<(tert-butylamino)methyl>acetanilide 在 盐酸 作用下， 以 乙醇 为溶剂， 生成 3-(tert-Butylamino-methyl)-4'-chloro-5-(7-chloro-1-oxy-quinolin-4-ylamino)-biphenyl-2-ol
  参考文献：
  名称：

  Antimalarial drugs. 60. Synthesis, antimalarial activity, and quantitative structure-activity relationships of tebuquine and a series of related 5-[(7-chloro-4-quinolinyl)amino]-3-[(alkylamino)methyl][1,1'-biphenyl]-2-ols and N.omega.-oxides

  摘要：

  A series of 5-[(7-chloro-4-quinolinyl)amino]-3-[(alkylamino)methyl] [1,1'-biphenyl]-2-ols and N omega-oxides was prepared from the substituted 1-phenyl-2-propanones proceeding through the 5-nitro[1,1'-biphenyl]-2-ols, the corresponding amino, and acetamido derivatives to the N-[5-[(alkylamino)methyl]-6-hydroxy[1,1'-biphenyl]-3-yl]acetamides and final condensation with 4,7-dichloroquinoline or the N-oxide. In a quantitative structure-activity relationship study first run on 28 and later expanded to 40 substituted phenyl analogues and their N omega-oxides, increasing antimalarial potency vs. Plasmodium berghei in mice was found to be correlated with decreasing size (sigma MR) and electron donation (sigma sigma) of the phenyl ring substituents. A significant correlation with N omega-oxidation could not be demonstrated. Initial high activity against P. berghei infections in mice led to expanded studies that demonstrated in addition excellent activity against resistant strains of parasite, activity in primate models, and pharmacokinetic properties apparently allowing protection against infection for extended periods of time even after oral administration. Such properties encourage the clinical trial of a member of this class in man.

  DOI：

  10.1021/jm00156a009
• 作为产物：
  描述：

  5-氨基-4'-氯[1,1'-联苯基]-2-醇 以 甲醇 、 乙醇 、 水 为溶剂， 生成 3-(4'-chlorophenyl)-4-hydroxy-5-<(tert-butylamino)methyl>acetanilide
  参考文献：
  名称：

  Antimalarial drugs. 60. Synthesis, antimalarial activity, and quantitative structure-activity relationships of tebuquine and a series of related 5-[(7-chloro-4-quinolinyl)amino]-3-[(alkylamino)methyl][1,1'-biphenyl]-2-ols and N.omega.-oxides

  摘要：

  A series of 5-[(7-chloro-4-quinolinyl)amino]-3-[(alkylamino)methyl] [1,1'-biphenyl]-2-ols and N omega-oxides was prepared from the substituted 1-phenyl-2-propanones proceeding through the 5-nitro[1,1'-biphenyl]-2-ols, the corresponding amino, and acetamido derivatives to the N-[5-[(alkylamino)methyl]-6-hydroxy[1,1'-biphenyl]-3-yl]acetamides and final condensation with 4,7-dichloroquinoline or the N-oxide. In a quantitative structure-activity relationship study first run on 28 and later expanded to 40 substituted phenyl analogues and their N omega-oxides, increasing antimalarial potency vs. Plasmodium berghei in mice was found to be correlated with decreasing size (sigma MR) and electron donation (sigma sigma) of the phenyl ring substituents. A significant correlation with N omega-oxidation could not be demonstrated. Initial high activity against P. berghei infections in mice led to expanded studies that demonstrated in addition excellent activity against resistant strains of parasite, activity in primate models, and pharmacokinetic properties apparently allowing protection against infection for extended periods of time even after oral administration. Such properties encourage the clinical trial of a member of this class in man.

  DOI：

  10.1021/jm00156a009

文献信息

• Synthesis, Antimalarial Activity, and Molecular Modeling of Tebuquine Analogues
  作者：Paul M. O'Neill、David J. Willock、Shaun R. Hawley、Patrick G. Bray、Richard C. Storr、Stephen A. Ward、B. Kevin Park

  DOI：10.1021/jm960370r

  日期：1997.2.1

  amodiaquine (2) and chloroquine (1) both in vitro and in vivo. We have developed a novel more efficient synthetic route to tebuquine analogues which involves the use of a palladium-catalyzed Suzuki reaction to introduce the 4-chlorophenyl moiety into the 4-hydroxyaniline side chain. Using similar methodology, novel synthetic routes to fluorinated (7a, b) and a dehydroxylated (7c) analogue of tebuquine

  Tebuquine（5）是一种4-氨基喹啉，在体外和体内均显着高于阿莫二喹（2）和氯喹（1）。我们已经开发了一种新的更有效的合成戊喹类似物的合成路线，该路线涉及使用钯催化的Suzuki反应将4-氯苯基部分引入到4-羟基苯胺侧链中。使用相似的方法，还开发了新颖的合成路线来合成戊丁喹的氟化物（7a，b）和脱羟基化的（7c）类似物。对新型类似物进行了针对恶性疟原虫对氯喹敏感的HB3菌株和耐氯喹的K1菌株的测试。戊丁喹是针对两种疟原虫菌株测试的最具活性的化合物。用氟或氢取代4-羟基官能团导致抗疟活性降低。戊丁喹类似物与氨二喹和氯喹的分子模型研究表明，这类药物中分离的双质子化形式的氮间分离范围在9.36至9.86 A之间，而在血红素-药物复合物中则在7.52至10.21 A之间。关于4-氨基喹啉与拟议的细胞受体血红素相互作用的进一步模型研究表明，氯喹，氨二喹和戊丁喹类似物具有良好的相互作用能。在真空
• WERBEL L. M.; COOK P. D.; ELSLAGER E. F.; HUNG J. H.; JOHNSON J. L.; KEST+, J. MED. CHEM., 29,(1986) N 6, 924-939
  作者：WERBEL L. M.、 COOK P. D.、 ELSLAGER E. F.、 HUNG J. H.、 JOHNSON J. L.、 KEST+

  DOI：——

  日期：——
• Substituted-5-((7-chloro-4-quinolinyl)amino)-3-(amino-methyl)-(1,1'-biphenyl)-2-ol compounds; processes for their production; and pharmaceutical compositions containing the compounds
  申请人：WARNER-LAMBERT COMPANY

  公开号：EP0027679B1

  公开（公告）日：1983-08-10